Probiotics for fibromyalgia: Study design for a pilot double-blind, randomized controlled trial;Probióticos en fibromialgia: Diseño de un estudio piloto doble ciego y randomizado

Nutricion Hospitalaria

Volumn 34, Issue 5, 2017, Pages 1246-1251

  Roman, Pablo ^a   Estévez, Ángeles F ^b   Sánchez Labraca, Nuria ^b   Cañadas, Fernando ^b   Miras, Alonso ^c   Cardona Mena, Diana ^b  

^a UNIVERSITAT JAUME I   (Spain)

^b UNIVERSITY OF ALMERÍA   (Spain)

^c NONE   (Spain)

Author keywords

Chronic pain; Clinical trial; Fibromyalgia; Nutrition; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ADULT; AGED; COMPLICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FIBROMYALGIA; HUMAN; MALE; MIDDLE AGED; PAIN; PILOT STUDY; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PAIN; PILOT PROJECTS; PROBIOTICS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 85034612159     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.20960/nh.1300     Document Type: Article

References (70)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33(2):160-72.
2. Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62(5):600-10.
3. Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep 2013;17(8):356.
4. Jones G, Atzeni F, Beasley M, Flüß E, Sarzi-Puttini P, Macfarlane GJ. The prevalence of fibromyalgia in the general population: A comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol 2015;67(2):568-75.
5. Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Häuser W, Katz RS, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 2011;38(6):1113-22.
6. Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 2000;160(2):221-7.
7. Triadafilopoulos G, Simms RW, Goldenberg DL. Bowel dysfunction in fibromyalgia syndrome. Dig Dis Sci 1991;36(1):59-64.
8. Riedl A, Schmidtmann M, Stengel A, Goebel M, Wisser A-S, Klapp BF, et al. Somatic comorbidities of irritable bowel syndrome: A systematic analysis. J Psychosom Res 2008;64(6):573-82.
9. Sperber AD, Atzmon Y, Neumann L, Weisberg I, Shalit Y, Abu-Shakrah M, et al. Fibromyalgia in the irritable bowel syndrome: Studies of prevalence and clinical implications. Am J Gastroenterol 1999;94(12):3541-6.
10. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? Gastroenterol 2002;122(4):1140-56.
11. Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 2001;134(9 Pt 2):868-81.
12. Kanaan RAA, Lepine JP, Wessely SC. The association or otherwise of the functional somatic syndromes. Psychosom Med 2007;69(9):855-9.
13. Glass JM, Park DC. Cognitive dysfunction in fibromyalgia. Curr Rheumatol Rep 2001;3(2):123-7.
14. Glass JM, Park DC, Minear M, Crofford LJ. Memory beliefs and function in fibromyalgia patients. J Psychosom Res 2005;58(3):263-9.
15. Glass JM. Fibromyalgia and cognition. J Clin Psychiatry 2008;69(Suppl 2):20-4.
16. Glass JM. Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: New trends and future directions. Curr Rheumatol Rep 2006;8(6):425-9.
17. Glass JM. Review of cognitive dysfunction in fibromyalgia: A convergence on working memory and attentional control impairments. Rheum Dis Clin North Am 2009;35(2):299-311.
18. Glass JM, Williams DA, Fernández-Sánchez ML, Kairys A, Barjola P, Heitzeg MM, et al. Executive function in chronic pain patients and healthy controls: Different cortical activation during response inhibition in fibromyalgia. J Pain 2011;12(12):1219-29.
19. Gelonch O, Garolera M, Rosselló L, Pifarré J. Cognitive dysfunction in fibromyalgia. Rev Neurol 2013;56(11):573-88.
20. Butt H, Dunstan R, McGregor N, Roberts T. Bacterial colonosis in patients with persistent fatigue. In: Proceedings of the AHMF international clinical and scientific conference; 2001.
21. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003;98(2):412-9.
22. Pimentel M, Wallace D, Hallegua D, Chow E, Kong Y, Park S, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis 2004;63(4):450-2.
23. Galland L. The gut microbiome and the brain. J Med Food 2014;17(12): 1261-72.
24. Slim M, Calandre EP, Rico-Villademoros F. An insight into the gastrointestinal component of fibromyalgia: Clinical manifestations and potential underlying mechanisms. Rheumatol Int 2015;35(3):433-44.
25. Lakhan SE, Kirchgessner A. Gut inflammation in chronic fatigue syndrome. Nutr Metab (Lond) 2010;7(1):79.
26. FAO/WHO. Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Prebiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Vol. 85, Food and Nutrition Paper; 2001. p. 71.
27. Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World J Gastroenterol 2015;21(10):3072-84.
28. Tiequn B, Guanqun C, Shuo Z. Therapeutic effects of Lactobacillus in treating irritable bowel syndrome: A meta-analysis. Intern Med 2015;54(3): 243-9.
29. Khalighi AR, Khalighi MR, Behdani R, Jamali J, Khosravi A, Kouhestani S, et al. Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO)-A pilot study. Indian J Med Res 2014;140(5):604-8.
30. Benton D, Williams C, Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 2007;61(3):355-61.
31. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2011;105(5):755-64.
32. Steenbergen L, Sellaro R, Van Hemert S, Bosch JA, Colzato LS. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun 2015;48:258-64.
33. Messaoudi M, Violle N, Bisson J-F, Desor D, Javelot H, Rougeot C. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2011;2(4):256-61.
34. Sherwin E, Rea K, Dinan TG, Cryan JF. A gut (microbiome) feeling about the brain. Curr Opin Gastroenterol 2016;32(2):96-102.
35. De Palma G, Collins SM, Bercik P, Verdu EF. The microbiota-gut-brain axis in gastrointestinal disorders: Stressed bugs, stressed brain or both? J Physiol 2014;592(14):2989-97.
36. Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: Intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 2008;29(1): 117-24.
37. Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol Q Publ Hell Soc Gastroenterol 2015;28(2):203-9.
38. Huang R, Wang K, Hu J. Effect of probiotics on depression: A systematic review and meta-analysis of randomized controlled trials. Nutrients 2016; 8(8).
39. Bravo JA, Forsythe P, Chew M V, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011;108(38):16050-5.
40. Wall R, Cryan JF, Ross RP, Fitzgerald GF, Dinan TG, Stanton C. Bacterial neuroactive compounds produced by psychobiotics. Adv Exp Med Biol 2014;817:221-39.
41. Tillisch K. The effects of gut microbiota on CNS function in humans. Gut Microbes 2014;5(3):404-10.
42. Cryan JF, O’Mahony SM. The microbiome-gut-brain axis: From bowel to behavior. Neurogastroenterol Motil 2011;23(3):187-92.
43. Cryan JF, Dinan TG. Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012;13(10):701-12.
44. Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 2011;108(7):3047-52.
45. Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med 2011;62:381-96.
46. McKean J, Naug H, Nikbakht E, Amiet B, Colson N. Probiotics and subclinical psychological symptoms in healthy participants: A systematic review and meta-analysis. J Altern Complement Med 2016;acm.2016.0023.
47. Huskisson EC. Measurement of pain. Lancet 1974;2(7889):1127-31.
48. Lahuerta J, Smith B, Martínez-Lage A. An adaptation of the McGill Pain Questionnaire to the Spanish language. Schmerz 1982;(3):132-4.
49. Alonso J, Prieto L, Antó JM. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): An instrument for measuring clinical results. Med Clin 1995;104(20):771-6.
50. Monterde S, Salvat I, Montull S, Fernández-Ballart J. Validación de la versión española del Fibromyalgia Impact Questionnaire. Rev Esp Reumatol 2004;31(9):507-13.
51. Macias J, Royuela A. La versión española del índice de calidad del sueño de Pittsburg. Inf Psiquiatr 1996 (146): 465-72.
52. Conde V, Useros E. Adaptación castellana de la escala de evaluación conductual para la depresión de Beck. Rev Psiquiat Psicol Med Eur Am Lat 1975(12):217-36.
53. Seisdedos N. Cuestionario de Ansiedad Estado-Rasgo [STAI]. Madrid: TEA; 1982.
54. Lobo A, Escobar V, Ezquerra J, Seva Díaz A. El Mini-Examen Cognoscitivo. Un test sencillo, práctico, para detectar alteraciones intelectuales en pacientes psiquiátricos. Rev Psiquiatr Psicol Med 1980;14(5):39-57.
55. Ibor J. Escala de inteligencia de Wechsler para adultos III. Schizophr Res 2005;(78):147-56.
56. Mäkelä R, Mäkilä H, Peltomaa R. Dietary therapy in patients with inflammatory arthritis. Altern Ther Health Med 2017;23(1):34-9.
57. Dinan TG, Quigley EM. Probiotics in the treatment of depression: Science or science fiction? Aust N Z J Psychiatry 2011;45(12):1023-5.
58. Hardy H, Harris J, Lyon E, Beal J, Foey AD. Probiotics, prebiotics and immunomodulation of gut mucosal defences: Homeostasis and immunopathology. Nutrients 2013;5(6):1869-912.
59. Upadhyay N, Moudgal V. Probiotics: A review. J Clin Outcomes Manag 2012; 19(2):76-84.
60. Dinan TG, Stanton C, Cryan JF. Psychobiotics: A novel class of psychotropic. Biol Psychiatry 2013;74(10):720-6.
61. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res 2008;43(2):164-74.
62. Martinowich K, Lu B. Interaction between BDNF and serotonin: Role in mood disorders. Neuropsychopharmacol 2008;33(1):73-83.
63. Othman M, Agüero R, Lin HC. Alterations in intestinal microbial flora and human disease. Curr Opin Gastroenterol 2008;24(1):11-6.
64. Verdejo-García A, López-Torrecillas F, Calandre EP, Delgado-Rodríguez A, Bechara A. Executive function and decision-making in women with fibromyalgia. Arch Clin Neuropsychol 2009;24(1):113-22.
65. Buchwald D, Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 1994; 154(18):2049-53.
66. Lorenzo-Zúñiga V, Llop E, Suárez C, Álvarez B, Abreu L, Espadaler J, et al. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol 2014;20(26):8709-16.
67. Francavilla R, Miniello V, Magista AM, De Canio A, Bucci N, Gagliardi F, et al. A randomized controlled trial of Lactobacillus gg in children with functional abdominal pain. Pediatrics 2010;126(6):e1445-52.
68. Konieczna P, Groeger D, Ziegler M, Frei R, Ferstl R, Shanahan F, et al. Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: Potential role for myeloid and plasmacytoid dendritic cells. Gut 2012;61(3):354-66.
69. Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM, et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog 2009;1(1):6.
70. Nüesch E, Häuser W, Bernardy K, Barth J, Jüni P. Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: Network meta-analysis. Ann Rheum Dis 2013;72(6):955-62.